Biotech
WHO grants emergency use of China’s Sinopharm

WHO added a Chinese shot to its list of COVID-19 vaccines approved for emergency use, providing COVAX another option to broaden vaccine access.

WHO lists Moderna vaccine for emergency use

WHO listed Moderna’s coronavirus vaccine for emergency use, the fifth such designation since the pandemic began and another step towards global access.

COVAX expands with World Bank backing

The World Bank approved US$2 billion in financing for COVID-19 vaccines in 17 developing countries as part of a two-year US$12 billion package.

Thunberg calls vaccine inequity a ‘moral test’

Swedish climate activist Greta Thunberg joined WHO in calling on rich nations to stop hoarding vaccines and start accelerating the spread of shots worldwide.

Delays foreseen with COVAX vaccine deliveries

International organizations acknowledged significant delays in delivering COVID-19 vaccines to poor nations due to pressure from India.

First WHO listing for one-shot COVID-19 vaccine

WHO approved Johnson & Johnson’s COVID-19 vaccine for emergency use, adding a fourth shot to the international arsenal of tools against the pandemic.

COVAX starts global vaccine push in Ghana

The COVAX Facility’s global rollout of COVID-19 vaccines finally launched with the delivery of 600,000 doses to Ghana’s capital Accra.

WHO lists first COVID-19 vaccine for emergency use

The WHO listed Pfizer-BioNTech’s coronavirus vaccine Comirnaty® for emergency use, the first such designation since the pandemic began earlier this year.

Vaccine approvals add promise for COVAX use

Britain and Argentina authorized emergency use of a coronavirus vaccine that adds momentum to its anticipated global use by international organizations.

E.U. regulator approves first COVID-19 vaccine

A two-shot vaccine from BioNTech and Pfizer gained official approval in the E.U., two days after Switzerland approved it through a normal procedure.

Swiss achieve first full-blown vaccine approval

Switzerland announced it has become the first government in the world to approve a coronavirus vaccine using a standard process of regulatory approval.

COVAX vaccine rollout gets 2 billion doses

The COVAX Facility has secured almost 2 billion doses of COVID-19 vaccine candidates for low-income and developing countries, organizations said.

Big pharma sees wide use of vaccines by late 2021

Several CEOs of leading drugmakers expressed confidence the pandemic can be brought under control starting sometime in the second half of next year.

WHO says new antibiotics pipeline thins

WHO At least 700,000 people a year die from drug-resistant diseases but only 50 antibiotics exist in the medical community pipeline of potential new drugs.